Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells
The differentiation of pluripotent stem cells to hepatocytes is well established, yet current methods suffer from several drawbacks. These include a lack of definition and reproducibility, which in part stems from continued reliance on recombinant growth factors. This has remained a stumbling block...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-05-01
|
Series: | Stem Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213671115001010 |
id |
doaj-dfd2242b8b684930baa4ddd8d67a9fdc |
---|---|
record_format |
Article |
spelling |
doaj-dfd2242b8b684930baa4ddd8d67a9fdc2020-11-25T01:57:23ZengElsevierStem Cell Reports2213-67112015-05-014593995210.1016/j.stemcr.2015.04.001Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem CellsRichard Siller0Sebastian Greenhough1Elena Naumovska2Gareth J. Sullivan3Department of Biochemistry, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, NorwayDepartment of Biochemistry, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, NorwayDepartment of Biochemistry, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, NorwayDepartment of Biochemistry, Faculty of Medicine, Institute of Basic Medical Sciences, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, NorwayThe differentiation of pluripotent stem cells to hepatocytes is well established, yet current methods suffer from several drawbacks. These include a lack of definition and reproducibility, which in part stems from continued reliance on recombinant growth factors. This has remained a stumbling block for the translation of the technology into industry and the clinic for reasons associated with cost and quality. We have devised a growth-factor-free protocol that relies on small molecules to differentiate human pluripotent stem cells toward a hepatic phenotype. The procedure can efficiently direct both human embryonic stem cells and induced pluripotent stem cells to hepatocyte-like cells. The final population of cells demonstrates marker expression at the transcriptional and protein levels, as well as key hepatic functions such as serum protein production, glycogen storage, and cytochrome P450 activity.http://www.sciencedirect.com/science/article/pii/S2213671115001010 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Richard Siller Sebastian Greenhough Elena Naumovska Gareth J. Sullivan |
spellingShingle |
Richard Siller Sebastian Greenhough Elena Naumovska Gareth J. Sullivan Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells Stem Cell Reports |
author_facet |
Richard Siller Sebastian Greenhough Elena Naumovska Gareth J. Sullivan |
author_sort |
Richard Siller |
title |
Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells |
title_short |
Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells |
title_full |
Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells |
title_fullStr |
Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells |
title_full_unstemmed |
Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells |
title_sort |
small-molecule-driven hepatocyte differentiation of human pluripotent stem cells |
publisher |
Elsevier |
series |
Stem Cell Reports |
issn |
2213-6711 |
publishDate |
2015-05-01 |
description |
The differentiation of pluripotent stem cells to hepatocytes is well established, yet current methods suffer from several drawbacks. These include a lack of definition and reproducibility, which in part stems from continued reliance on recombinant growth factors. This has remained a stumbling block for the translation of the technology into industry and the clinic for reasons associated with cost and quality. We have devised a growth-factor-free protocol that relies on small molecules to differentiate human pluripotent stem cells toward a hepatic phenotype. The procedure can efficiently direct both human embryonic stem cells and induced pluripotent stem cells to hepatocyte-like cells. The final population of cells demonstrates marker expression at the transcriptional and protein levels, as well as key hepatic functions such as serum protein production, glycogen storage, and cytochrome P450 activity. |
url |
http://www.sciencedirect.com/science/article/pii/S2213671115001010 |
work_keys_str_mv |
AT richardsiller smallmoleculedrivenhepatocytedifferentiationofhumanpluripotentstemcells AT sebastiangreenhough smallmoleculedrivenhepatocytedifferentiationofhumanpluripotentstemcells AT elenanaumovska smallmoleculedrivenhepatocytedifferentiationofhumanpluripotentstemcells AT garethjsullivan smallmoleculedrivenhepatocytedifferentiationofhumanpluripotentstemcells |
_version_ |
1724974440710668288 |